Kevin Lee Freeman, Chief Commercial Officer at Health Catalyst, Inc. (HCAT), sold 7,500 shares at $6.53 ($49K) on 2024-06-11, disclosed to the SEC on 2024-06-12.
Scheduled sale ($49k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |